Effects of graphene oxide nanoparticles administration against reserpine-induced neurobehavioral damage and oxidative stress in an animal model of Parkinson's disease
- 24 June 2023
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 178, 113904
Abstract
No abstract availableKeywords
Funding Information
- University of Texas Medical Branch
This publication has 42 references indexed in Scilit:
- Graphene Oxide: Preparation, Functionalization, and Electrochemical ApplicationsChemical Reviews, 2012
- Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's diseaseBehavioural Brain Research, 2012
- Cost of disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Graphene Oxide, Highly Reduced Graphene Oxide, and Graphene: Versatile Building Blocks for Carbon‐Based MaterialsSmall, 2010
- Management of non-motor complications in Parkinson’s diseaseJournal of Neurology, 2009
- Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA modelJournal of Neuroscience Methods, 2006
- Assaying for superoxide dismutase activity: Some large consequences of minor changes in conditionsAnalytical Biochemistry, 1987
- [13] Catalase in vitro1984
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Strain differences in open-field behavior of the ratPsychonomic Science, 1972